SlideShare a Scribd company logo
Measurement of Disease
Frequency
Occurrence and Trends
Module 1
Measurement of Disease
for Outbreaks and Trends
• Measurement of disease burden
• Prevalence, Proportion, % etc
• Measurement of disease occurrence
• Incidence, death rate,
• Measurement of association (risk vs outcome)
• Odds Ratio, RR
• Measurement of Trends and Distributions**
• Dose – response, Trends over time cohort (APC)
• Time Series etc.
Measurement of disease burden
• Count (number) and unit of count (such as
aggregate number – group, cluster, flock etc)
• Count and proportion (number of case per
survey population, %, ratio – m:f)
• Prevalence (magnitude)
Prevalence
Prevalence =
Number of existing cases at a point of time
Average size of the population at the period of time
Prevalence =
No. of existing cases + new cases during a period of time
Size of the population at a point of time
(point)
period
Prevalence (point)
Prevalence =
Number of DM cases in the survey of a village
Size of the population of the village
(point)
=
36
3200 villager
= 0.01125 Or 1.12 person in 100 people
Prevalence
Average size of the population at the period of time
Prevalence =
No. of existing cases + new cases during a period of time
period
=
36 + 12 In 6 months period
3200 villager + 200 (birth and move in, minus died)
= 48
3400
= 0.0141 Or 1.4 in 100 villager
Measurement of disease occurrence
Incidence (rate) =
No. of FMD in cows in 1 year
Size of population at risk who stay in the area in 1 year
=
New cases occur in an observed period ( 1 year)
Population of cows in the province in 1 year
=
500
2500
= 200 FMD per 1000 Cows per year
X 1000 or 100000
X 10000
Incidence is rate of change : unit of calculation is per time (t minus 1)
(incidence rate, death rate etc.
Common measurement in descriptive epidemiology
• Count
• Ratio (A:B) such as M:F
• Proportion (of Total, of school attendant)
• Percentage %
• Prevalence
• Rate (of change) – incidence
• Case Fatality Rate : CFR) - proportion
• Summary of data variable (Mean, Median, Mode)
Number of patients with “D” disease reported from
all hospitals in Province/Division ‘M’ by week, in 201X
Hospital
Area Total 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Provineial H 1778 112 112 101 101 112 116 100 101 127 123 89 85 87 103 63 86 75 68 7
Hosp A 163 28 31 26 28 13 12 9 5 11
Hosp B 5 1 1 1 1 1
Hosp C 169 24 16 14 22 25 23 20 4 1 2 16
Hosp D 656 44 37 48 44 27 21 43 24 24 19 14 39 28 43 41 45 34 39 28
Hosp E 466 19 33 36 38 28 20 40 23 16 21 27 16 21 21 14 27 18 24 22
Hosp F 226 17 17 26 23 47 26 41 22 2
Hosp G 242 27 18 25 33 21 20 33 18 28 17 1
Understand sources of data
and how data collected
• Definition of case required for notification
• Surveillance and reporting system (and
requirement – such as priority/urgent etc)
• Reporting Persons, organization
• Timeliness
• Completion
• Evaluation and supervision
• Technology
Previous slide content show
• Count per week
• Count of cases among different hospital/area
• No report and missing data
• Incomplete information in some data
• No information, no data – difficult to analyze or
interpretation
• No population in each area make it hard to
compare the problem
• Can we say something about the trends of
disease?
John Snow : Observation and study of
Cholera Outbreak, London 1854
Cholera cases, rate per HH
By water supplied company, London 1854.
Southwark & Vauxhall 40,046 1,263 315
Company
Lamberth Company 26,107 98 37
Rest of London 256,423 1,422 59
Tap water
Supplied company
No. HH cases
Case per
10000 HH
Measure of disease transmission
 Index – first case identified
 Primary – case that brings the infection into a population
 Secondary – infected by a primary case
 Tertiary – infected by a secondary case
P
S
S
T
Susceptible
Immune
Asymptomatic
Clinical
S
T
การถ่ายทอดโรค (Disease Transmission)
Transmission: Reproductive Number
Basic Reproductive Number (R zero)
Secondary cases occurred as a result of
exposure (contact) to indexed cases or
previous case
Ro = between 1-2 from this example
After an ILI index case ill in families
no. of new cases sick in 1 incubation period
Size of families New case occur Index to new case ratio
5 2 1:2
4 2 1:2
3 1 1:1
6 3 1:3
Estimated Ro
in selected infectious disease
• Seasonal Influenza (2-4)
• Pandemic A/H1N1 (2-5)
• H5N1 (0.5-2)
• SARs (3-7****)
• Tuberculosis (1-2)***
• MERS (0.7-4**)
• Ebola (1-5**)
• HFMD (1-6**)
** depend on settings, family size, contact methods, procedure
First MERS in Korea and transmission
Transmission Relationships
Measurement of association (risk vs outcome)
Odds Ratio, RR
Terminology
• Variable (things with information of interest : Sex,
age, Blood sugar, Infection (Y/N), eat food A, bite by
rabid dog, vaccination) (y/n)……etc)
• Association ( possible relationship of x and y)
• Correlation (how x and y go together) (+/-)
• Some association can be cause-effect
relationship
Measurement of association (risk vs outcome)
Odds Ratio, RR
Association
• What is Odd and Odds Ration
a:b is Odd of X ( c:d is another odd of Y)
X:Y is Odds Ratio
• What is Relative Risk (similar concept
“Studies showed “Drink alcohol” associated with increase in road accident by 3 times”
Calculation format Odd, Odds Ratio
Accident No accident
Drinking “alcohol”
Over 75 mg%
a b a+b
No alcohol c d c+d
a+c b+d N = a+b+c+d
Accident No accident
Drinking “alcohol”
Over 75 mg%
a b a+b
No alcohol c d c+d
a+c b+d N =
a+b+c+d
Odd of accident in drinking = a/b
Odd of accident in No drinking = c/d
Odd Ratio of Alcohol in accident = (a/b) /(c/d) = a*d /b*c
ORs = number
+ Calculate 95% Confident Intervals
Accident No accident
Drinking “alcohol”
Over 75 mg%
50 500 550
No alcohol 5 1200 1205
55 1700 1755
Odd of accident in drinking = a/b = 50/500 = 0.1
Odd of accident in No drinking = c/d = 5/1200 = 0.00416
Odd Ratio of Alcohol in accident = (0.1) /(0.00416) = 24.04 times
ORs = number
+ Calculate 95% Confident Intervals
Calculation format RR, RRs Ratio
Case Measles Normal (child) no
illness
MMR vaccination
a b a+b
No MMR
vaccination
c d c+d
a+c b+d N = a+b+c+d
Case Measles Normal (child) no
illness
MMR vaccination a b a+b
No MMR
vaccination
c d c+d
a+c b+d N = a+b+c+d
RR of disease in vaccination = a/a+b
RR of disease in non-vaccination = c/c+d
RRs Ratio is = a(a+b)/(c /(c+d))
Case Measles Normal (child) no
illness
MMR vaccination 5 400 405
No MMR
vaccination
28 300 328
33 730 763
RR of disease in vaccination = a/a+b = 5/405 = 0.012
RR of disease in non-vaccination = c/c+d = 28/328 = 0.0853
RRs Ratio is = a(a+b)/(c /(c+d))
= 0.012/0.0853 = 0.14
MMR vaccination has 7.1 time protective effect or approximately 76 % efficacy
Cause-effect Association
• Strength of association (high RRs, Ors)
• Consistency
• Specificity
• Temporal relation (A happened before disease)
• Biological Plausibility
• Dose-response relationship
• Coherence
• Experiment support
• Analogy **
** too weak , may not be necessary
Q/A
Thank you
Trends Analysis (advance)
For your interest only
For use in future
Time series analysis
Temperature, NE Thailand
1975 1980 1985 1990 1995 2000 2005 2010
20
22
24
26
28
30
C
Main composition of determinants
of a Time Series
• Trend: linear, curvinear, moving average
• Oscillation (cosine function)
– Harmonic terms e.g. cos(a), cos(2a)
– Starting points e.g. cos(m+a), cos(n+2a)
• Autoregressive effect
– Preceding status has effects on the current one.
• Optionally other explanatory independent terms e.g.
temperature, rainfalls, which are beyond the trend
and cyclical effects
• Random errors
Temperature, NE Thailand
1975 1980 1985 1990 1995 2000 2005 2010
20
22
24
26
28
30
C
Analysis : Output from R program - red line show
trend of temperature with seasonal (time) variation
202224262830
observed
25.025.526.026.5
trend
-4-3-2-1012
seasonal
-3-101234
1975 1980 1985 1990 1995 2000 2005 2010
random
Time
Decomposition of additive time series
Forecasting malaria in Yalamalaria
2000 2005 2010 2015
0
500
1000
1500
การเปลี่ยนแปลงหลังการระบาดใหญ่ ๕ ปี ของไข้หวัดใหญ่สายพันธ์ใหม่ 2009
Age-Period-Cohort (APC)
• Age – risk of disease depend on age such as
– Low immunity in children
– Exposure to chemical, hormone change
– Age related disease, elderly less immunity etc
• Period : certain period living aspect change (60s,
80s, 90s, 2000s, 2010….)
• Cohort : Birth cohort experienced different
era/period
• Interaction for risk factors
Hutcha Sriplung Thai Network of Cancer Registries 40
Female breast cancer in Thailand
Year
1989199019911992199319941995199619971998199920002001200220032004200520062007
0
5
10
15
20
25
30
Breast Cancer
Thailand, 1989-2007
Chiang Mai
Lampang
Khon Kaen
Songkhla
Year
ASR(per100000population
Hutcha Sriplung Thai Network of Cancer Registries 41
Male colo-rectal cancer in Thailand
89 90 91 92 93 94 95 96 97 98 99 00
0
5
10
15
20
25
Chiang Mai
Lampang
Khon Kaen
Songkhla
Year
ASR /100,000 population
Hutcha Sriplung Thai Network of Cancer Registries 42
Tobacco consumption and lung cancer
in Australia
1945
1947
1949
1951
1953
1955
1957
1959
1961
1963
1965
1967
1969
1971
1973
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
Lung Cancer-Male
Lung Cancer-Female
Tobacco consumption
3.0
1.5
0.0
2.0
1.0
2.5
Tobacco
Kg/capita
Death/100,000
population
Year
AIHW: deloop M & Bhatia K 2001: Australian Health Trends 2001. AIHW Cat. No. PHE 24. Canberra: AIHW; the National Mortality
Database.
~20 years
The End – Thank you

More Related Content

What's hot

Epidemiological study designs
Epidemiological study designs Epidemiological study designs
Epidemiological study designs
Tauseef Jawaid
 
Prevalence and incidence
Prevalence and incidencePrevalence and incidence
Prevalence and incidence
Adhin Antony Xavier
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
Miharbi Ignasm
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
Dalia El-Shafei
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
Ismail Qamar
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort studyBhumika Bhatt
 
Measures Of Association
Measures Of AssociationMeasures Of Association
Measures Of Association
ganesh kumar
 
Infectious disease epidemiology
Infectious disease epidemiologyInfectious disease epidemiology
Infectious disease epidemiology
Jayaramachandran S
 
DESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGYDESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGY
Shyam Chaturvedi
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
Subraham Pany
 
Standardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil TumainiStandardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil Tumaini
Basil Tumaini
 
Bias, confounding and fallacies in epidemiology
Bias, confounding and fallacies in epidemiologyBias, confounding and fallacies in epidemiology
Bias, confounding and fallacies in epidemiologyTauseef Jawaid
 
Basic concepts and principles of epidemiology
Basic concepts and  principles of epidemiologyBasic concepts and  principles of epidemiology
Basic concepts and principles of epidemiology
Dr. Dharmendra Gahwai
 
CASE CONTROL STUDY
CASE CONTROL STUDYCASE CONTROL STUDY
CASE CONTROL STUDY
Vineetha K
 
Measures of Mortality
Measures of MortalityMeasures of Mortality
Measures of Mortality
Akhilesh Bhargava
 
Measurement of morbidity
Measurement of morbidityMeasurement of morbidity
Measurement of morbidity
drjagannath
 
Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studies
Dr Lipilekha Patnaik
 
Nested case control,
Nested case control,Nested case control,
Nested case control,
shefali jain
 
Introduction to Epidemiology
Introduction to EpidemiologyIntroduction to Epidemiology
Introduction to Epidemiology
Aya Mohamed
 
8 principle of epidemiology 11 community medicine
8 principle of epidemiology 11 community medicine8 principle of epidemiology 11 community medicine
8 principle of epidemiology 11 community medicineSiham Gritly
 

What's hot (20)

Epidemiological study designs
Epidemiological study designs Epidemiological study designs
Epidemiological study designs
 
Prevalence and incidence
Prevalence and incidencePrevalence and incidence
Prevalence and incidence
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
 
Measures Of Association
Measures Of AssociationMeasures Of Association
Measures Of Association
 
Infectious disease epidemiology
Infectious disease epidemiologyInfectious disease epidemiology
Infectious disease epidemiology
 
DESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGYDESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGY
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
 
Standardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil TumainiStandardization of rates by Dr. Basil Tumaini
Standardization of rates by Dr. Basil Tumaini
 
Bias, confounding and fallacies in epidemiology
Bias, confounding and fallacies in epidemiologyBias, confounding and fallacies in epidemiology
Bias, confounding and fallacies in epidemiology
 
Basic concepts and principles of epidemiology
Basic concepts and  principles of epidemiologyBasic concepts and  principles of epidemiology
Basic concepts and principles of epidemiology
 
CASE CONTROL STUDY
CASE CONTROL STUDYCASE CONTROL STUDY
CASE CONTROL STUDY
 
Measures of Mortality
Measures of MortalityMeasures of Mortality
Measures of Mortality
 
Measurement of morbidity
Measurement of morbidityMeasurement of morbidity
Measurement of morbidity
 
Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studies
 
Nested case control,
Nested case control,Nested case control,
Nested case control,
 
Introduction to Epidemiology
Introduction to EpidemiologyIntroduction to Epidemiology
Introduction to Epidemiology
 
8 principle of epidemiology 11 community medicine
8 principle of epidemiology 11 community medicine8 principle of epidemiology 11 community medicine
8 principle of epidemiology 11 community medicine
 

Similar to Measurement of disease frequency

MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
Bernard Deepal W. Jayamanne
 
Measures of association 2013
Measures of association 2013Measures of association 2013
Measures of association 2013dinahoefer11
 
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACTMEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
Aneesa K Ayoob
 
epiet-22- Logistic regression 2006-1.ppt
epiet-22- Logistic regression 2006-1.pptepiet-22- Logistic regression 2006-1.ppt
epiet-22- Logistic regression 2006-1.ppt
ssuser031f35
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
mehr92
 
Logistic regression1
Logistic regression1Logistic regression1
Logistic regression1
LoiLe36
 
Sutra model ibm
Sutra model   ibmSutra model   ibm
Sutra model ibm
VandanaVats8
 
4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt
OwomugishaMartin
 
Njilla steev ppt on summary measures
Njilla steev ppt on summary measuresNjilla steev ppt on summary measures
Njilla steev ppt on summary measures
njillasteev-becca
 
Epidemiology Lectures for UG
Epidemiology Lectures for UG Epidemiology Lectures for UG
Epidemiology Lectures for UG
amitakashyap1
 
ChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdfChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdf
Dikshathawait
 
Ph250b.14 measures of disease part 2 fri sep 5 2014
Ph250b.14 measures of disease part 2  fri sep 5 2014 Ph250b.14 measures of disease part 2  fri sep 5 2014
Ph250b.14 measures of disease part 2 fri sep 5 2014
A M
 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
Dhan Pandey
 
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptxEPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
TofikMohammadMuse
 
Research methodology and iostatistics ppt
Research methodology and iostatistics pptResearch methodology and iostatistics ppt
Research methodology and iostatistics ppt
Nikhat Mohammadi
 
Statistics.pdf.pdf for Research Physiotherapy and Occupational Therapy
Statistics.pdf.pdf for Research Physiotherapy and Occupational TherapyStatistics.pdf.pdf for Research Physiotherapy and Occupational Therapy
Statistics.pdf.pdf for Research Physiotherapy and Occupational Therapy
SakhileKhoza2
 
Mesurement epidemiology
Mesurement epidemiologyMesurement epidemiology
Mesurement epidemiology
Kailash Nagar
 
Measurement Epidemiology
Measurement EpidemiologyMeasurement Epidemiology
Measurement Epidemiology
Kailash Nagar
 
Statistics
StatisticsStatistics

Similar to Measurement of disease frequency (20)

MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
 
Measures of association 2013
Measures of association 2013Measures of association 2013
Measures of association 2013
 
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACTMEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
MEASURES OF DISEASE FREQUENCY. ASSOSCIATION AND IMPACT
 
epiet-22- Logistic regression 2006-1.ppt
epiet-22- Logistic regression 2006-1.pptepiet-22- Logistic regression 2006-1.ppt
epiet-22- Logistic regression 2006-1.ppt
 
Basic epidemiologic concept
Basic epidemiologic conceptBasic epidemiologic concept
Basic epidemiologic concept
 
Logistic regression1
Logistic regression1Logistic regression1
Logistic regression1
 
Sutra model ibm
Sutra model   ibmSutra model   ibm
Sutra model ibm
 
4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt4Estimating Disease Frequency occurrence-2024.ppt
4Estimating Disease Frequency occurrence-2024.ppt
 
Njilla steev ppt on summary measures
Njilla steev ppt on summary measuresNjilla steev ppt on summary measures
Njilla steev ppt on summary measures
 
Epidemiology Lectures for UG
Epidemiology Lectures for UG Epidemiology Lectures for UG
Epidemiology Lectures for UG
 
ChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdfChandanChakrabarty_1.pdf
ChandanChakrabarty_1.pdf
 
Ph250b.14 measures of disease part 2 fri sep 5 2014
Ph250b.14 measures of disease part 2  fri sep 5 2014 Ph250b.14 measures of disease part 2  fri sep 5 2014
Ph250b.14 measures of disease part 2 fri sep 5 2014
 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
 
Healthcare Workers’ Risks and Handling Exposures
Healthcare Workers’ Risks and Handling ExposuresHealthcare Workers’ Risks and Handling Exposures
Healthcare Workers’ Risks and Handling Exposures
 
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptxEPI_-_EPIDEMIOLOGIC_MEASURES  in public health .pptx
EPI_-_EPIDEMIOLOGIC_MEASURES in public health .pptx
 
Research methodology and iostatistics ppt
Research methodology and iostatistics pptResearch methodology and iostatistics ppt
Research methodology and iostatistics ppt
 
Statistics.pdf.pdf for Research Physiotherapy and Occupational Therapy
Statistics.pdf.pdf for Research Physiotherapy and Occupational TherapyStatistics.pdf.pdf for Research Physiotherapy and Occupational Therapy
Statistics.pdf.pdf for Research Physiotherapy and Occupational Therapy
 
Mesurement epidemiology
Mesurement epidemiologyMesurement epidemiology
Mesurement epidemiology
 
Measurement Epidemiology
Measurement EpidemiologyMeasurement Epidemiology
Measurement Epidemiology
 
Statistics
StatisticsStatistics
Statistics
 

More from EhealthMoHS

Nccpe report 2017
Nccpe report 2017Nccpe report 2017
Nccpe report 2017
EhealthMoHS
 
Myanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation planMyanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation plan
EhealthMoHS
 
Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)
EhealthMoHS
 
Module 6 emergency response
Module 6 emergency responseModule 6 emergency response
Module 6 emergency response
EhealthMoHS
 
Module 5 shipping & transportation of inf materials 21 1-2018
Module 5 shipping & transportation of inf materials 21 1-2018Module 5 shipping & transportation of inf materials 21 1-2018
Module 5 shipping & transportation of inf materials 21 1-2018
EhealthMoHS
 
Module 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazardModule 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazard
EhealthMoHS
 
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
EhealthMoHS
 
Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)
EhealthMoHS
 
Medical store management for smo
Medical store management for smoMedical store management for smo
Medical store management for smo
EhealthMoHS
 
Measles verification case definitions
Measles verification case definitionsMeasles verification case definitions
Measles verification case definitions
EhealthMoHS
 
Measles lecture 7.11.17
Measles lecture 7.11.17Measles lecture 7.11.17
Measles lecture 7.11.17
EhealthMoHS
 
Measles dr. al
Measles dr. alMeasles dr. al
Measles dr. al
EhealthMoHS
 
Maintain polio free status
Maintain polio free statusMaintain polio free status
Maintain polio free status
EhealthMoHS
 
Lec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohsLec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohs
EhealthMoHS
 
Lec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohsLec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohs
EhealthMoHS
 
Lec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohsLec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohs
EhealthMoHS
 
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
Lec 12 management of rheumatic fever   rheumatic heart disease for mohsLec 12 management of rheumatic fever   rheumatic heart disease for mohs
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
EhealthMoHS
 
Lec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohsLec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohs
EhealthMoHS
 
Lec 10 screening of diabetes mellitus for mohs
Lec 10 screening of diabetes mellitus for mohsLec 10 screening of diabetes mellitus for mohs
Lec 10 screening of diabetes mellitus for mohs
EhealthMoHS
 

More from EhealthMoHS (20)

Nccpe report 2017
Nccpe report 2017Nccpe report 2017
Nccpe report 2017
 
Myanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation planMyanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation plan
 
Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)
 
Mva
MvaMva
Mva
 
Module 6 emergency response
Module 6 emergency responseModule 6 emergency response
Module 6 emergency response
 
Module 5 shipping & transportation of inf materials 21 1-2018
Module 5 shipping & transportation of inf materials 21 1-2018Module 5 shipping & transportation of inf materials 21 1-2018
Module 5 shipping & transportation of inf materials 21 1-2018
 
Module 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazardModule 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazard
 
Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18Module 3 biosafety principles & microbiologycal risk group 21 1-18
Module 3 biosafety principles & microbiologycal risk group 21 1-18
 
Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)
 
Medical store management for smo
Medical store management for smoMedical store management for smo
Medical store management for smo
 
Measles verification case definitions
Measles verification case definitionsMeasles verification case definitions
Measles verification case definitions
 
Measles lecture 7.11.17
Measles lecture 7.11.17Measles lecture 7.11.17
Measles lecture 7.11.17
 
Measles dr. al
Measles dr. alMeasles dr. al
Measles dr. al
 
Maintain polio free status
Maintain polio free statusMaintain polio free status
Maintain polio free status
 
Lec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohsLec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohs
 
Lec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohsLec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohs
 
Lec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohsLec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohs
 
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
Lec 12 management of rheumatic fever   rheumatic heart disease for mohsLec 12 management of rheumatic fever   rheumatic heart disease for mohs
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
 
Lec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohsLec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohs
 
Lec 10 screening of diabetes mellitus for mohs
Lec 10 screening of diabetes mellitus for mohsLec 10 screening of diabetes mellitus for mohs
Lec 10 screening of diabetes mellitus for mohs
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 

Measurement of disease frequency

  • 2. Measurement of Disease for Outbreaks and Trends • Measurement of disease burden • Prevalence, Proportion, % etc • Measurement of disease occurrence • Incidence, death rate, • Measurement of association (risk vs outcome) • Odds Ratio, RR • Measurement of Trends and Distributions** • Dose – response, Trends over time cohort (APC) • Time Series etc.
  • 3. Measurement of disease burden • Count (number) and unit of count (such as aggregate number – group, cluster, flock etc) • Count and proportion (number of case per survey population, %, ratio – m:f) • Prevalence (magnitude)
  • 4. Prevalence Prevalence = Number of existing cases at a point of time Average size of the population at the period of time Prevalence = No. of existing cases + new cases during a period of time Size of the population at a point of time (point) period
  • 5. Prevalence (point) Prevalence = Number of DM cases in the survey of a village Size of the population of the village (point) = 36 3200 villager = 0.01125 Or 1.12 person in 100 people
  • 6. Prevalence Average size of the population at the period of time Prevalence = No. of existing cases + new cases during a period of time period = 36 + 12 In 6 months period 3200 villager + 200 (birth and move in, minus died) = 48 3400 = 0.0141 Or 1.4 in 100 villager
  • 7. Measurement of disease occurrence Incidence (rate) = No. of FMD in cows in 1 year Size of population at risk who stay in the area in 1 year = New cases occur in an observed period ( 1 year) Population of cows in the province in 1 year = 500 2500 = 200 FMD per 1000 Cows per year X 1000 or 100000 X 10000 Incidence is rate of change : unit of calculation is per time (t minus 1) (incidence rate, death rate etc.
  • 8. Common measurement in descriptive epidemiology • Count • Ratio (A:B) such as M:F • Proportion (of Total, of school attendant) • Percentage % • Prevalence • Rate (of change) – incidence • Case Fatality Rate : CFR) - proportion • Summary of data variable (Mean, Median, Mode)
  • 9. Number of patients with “D” disease reported from all hospitals in Province/Division ‘M’ by week, in 201X Hospital Area Total 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Provineial H 1778 112 112 101 101 112 116 100 101 127 123 89 85 87 103 63 86 75 68 7 Hosp A 163 28 31 26 28 13 12 9 5 11 Hosp B 5 1 1 1 1 1 Hosp C 169 24 16 14 22 25 23 20 4 1 2 16 Hosp D 656 44 37 48 44 27 21 43 24 24 19 14 39 28 43 41 45 34 39 28 Hosp E 466 19 33 36 38 28 20 40 23 16 21 27 16 21 21 14 27 18 24 22 Hosp F 226 17 17 26 23 47 26 41 22 2 Hosp G 242 27 18 25 33 21 20 33 18 28 17 1
  • 10. Understand sources of data and how data collected • Definition of case required for notification • Surveillance and reporting system (and requirement – such as priority/urgent etc) • Reporting Persons, organization • Timeliness • Completion • Evaluation and supervision • Technology
  • 11. Previous slide content show • Count per week • Count of cases among different hospital/area • No report and missing data • Incomplete information in some data • No information, no data – difficult to analyze or interpretation • No population in each area make it hard to compare the problem • Can we say something about the trends of disease?
  • 12. John Snow : Observation and study of Cholera Outbreak, London 1854
  • 13. Cholera cases, rate per HH By water supplied company, London 1854. Southwark & Vauxhall 40,046 1,263 315 Company Lamberth Company 26,107 98 37 Rest of London 256,423 1,422 59 Tap water Supplied company No. HH cases Case per 10000 HH
  • 14. Measure of disease transmission
  • 15.  Index – first case identified  Primary – case that brings the infection into a population  Secondary – infected by a primary case  Tertiary – infected by a secondary case P S S T Susceptible Immune Asymptomatic Clinical S T การถ่ายทอดโรค (Disease Transmission)
  • 16. Transmission: Reproductive Number Basic Reproductive Number (R zero) Secondary cases occurred as a result of exposure (contact) to indexed cases or previous case Ro = between 1-2 from this example
  • 17. After an ILI index case ill in families no. of new cases sick in 1 incubation period Size of families New case occur Index to new case ratio 5 2 1:2 4 2 1:2 3 1 1:1 6 3 1:3
  • 18. Estimated Ro in selected infectious disease • Seasonal Influenza (2-4) • Pandemic A/H1N1 (2-5) • H5N1 (0.5-2) • SARs (3-7****) • Tuberculosis (1-2)*** • MERS (0.7-4**) • Ebola (1-5**) • HFMD (1-6**) ** depend on settings, family size, contact methods, procedure
  • 19. First MERS in Korea and transmission
  • 21. Measurement of association (risk vs outcome) Odds Ratio, RR Terminology • Variable (things with information of interest : Sex, age, Blood sugar, Infection (Y/N), eat food A, bite by rabid dog, vaccination) (y/n)……etc) • Association ( possible relationship of x and y) • Correlation (how x and y go together) (+/-) • Some association can be cause-effect relationship
  • 22. Measurement of association (risk vs outcome) Odds Ratio, RR Association • What is Odd and Odds Ration a:b is Odd of X ( c:d is another odd of Y) X:Y is Odds Ratio • What is Relative Risk (similar concept “Studies showed “Drink alcohol” associated with increase in road accident by 3 times”
  • 23. Calculation format Odd, Odds Ratio Accident No accident Drinking “alcohol” Over 75 mg% a b a+b No alcohol c d c+d a+c b+d N = a+b+c+d
  • 24. Accident No accident Drinking “alcohol” Over 75 mg% a b a+b No alcohol c d c+d a+c b+d N = a+b+c+d Odd of accident in drinking = a/b Odd of accident in No drinking = c/d Odd Ratio of Alcohol in accident = (a/b) /(c/d) = a*d /b*c ORs = number + Calculate 95% Confident Intervals
  • 25. Accident No accident Drinking “alcohol” Over 75 mg% 50 500 550 No alcohol 5 1200 1205 55 1700 1755 Odd of accident in drinking = a/b = 50/500 = 0.1 Odd of accident in No drinking = c/d = 5/1200 = 0.00416 Odd Ratio of Alcohol in accident = (0.1) /(0.00416) = 24.04 times ORs = number + Calculate 95% Confident Intervals
  • 26. Calculation format RR, RRs Ratio Case Measles Normal (child) no illness MMR vaccination a b a+b No MMR vaccination c d c+d a+c b+d N = a+b+c+d
  • 27. Case Measles Normal (child) no illness MMR vaccination a b a+b No MMR vaccination c d c+d a+c b+d N = a+b+c+d RR of disease in vaccination = a/a+b RR of disease in non-vaccination = c/c+d RRs Ratio is = a(a+b)/(c /(c+d))
  • 28. Case Measles Normal (child) no illness MMR vaccination 5 400 405 No MMR vaccination 28 300 328 33 730 763 RR of disease in vaccination = a/a+b = 5/405 = 0.012 RR of disease in non-vaccination = c/c+d = 28/328 = 0.0853 RRs Ratio is = a(a+b)/(c /(c+d)) = 0.012/0.0853 = 0.14 MMR vaccination has 7.1 time protective effect or approximately 76 % efficacy
  • 29. Cause-effect Association • Strength of association (high RRs, Ors) • Consistency • Specificity • Temporal relation (A happened before disease) • Biological Plausibility • Dose-response relationship • Coherence • Experiment support • Analogy ** ** too weak , may not be necessary
  • 31. Trends Analysis (advance) For your interest only For use in future
  • 33. Temperature, NE Thailand 1975 1980 1985 1990 1995 2000 2005 2010 20 22 24 26 28 30 C
  • 34. Main composition of determinants of a Time Series • Trend: linear, curvinear, moving average • Oscillation (cosine function) – Harmonic terms e.g. cos(a), cos(2a) – Starting points e.g. cos(m+a), cos(n+2a) • Autoregressive effect – Preceding status has effects on the current one. • Optionally other explanatory independent terms e.g. temperature, rainfalls, which are beyond the trend and cyclical effects • Random errors
  • 35. Temperature, NE Thailand 1975 1980 1985 1990 1995 2000 2005 2010 20 22 24 26 28 30 C Analysis : Output from R program - red line show trend of temperature with seasonal (time) variation
  • 36. 202224262830 observed 25.025.526.026.5 trend -4-3-2-1012 seasonal -3-101234 1975 1980 1985 1990 1995 2000 2005 2010 random Time Decomposition of additive time series
  • 37. Forecasting malaria in Yalamalaria 2000 2005 2010 2015 0 500 1000 1500
  • 38. การเปลี่ยนแปลงหลังการระบาดใหญ่ ๕ ปี ของไข้หวัดใหญ่สายพันธ์ใหม่ 2009
  • 39. Age-Period-Cohort (APC) • Age – risk of disease depend on age such as – Low immunity in children – Exposure to chemical, hormone change – Age related disease, elderly less immunity etc • Period : certain period living aspect change (60s, 80s, 90s, 2000s, 2010….) • Cohort : Birth cohort experienced different era/period • Interaction for risk factors
  • 40. Hutcha Sriplung Thai Network of Cancer Registries 40 Female breast cancer in Thailand Year 1989199019911992199319941995199619971998199920002001200220032004200520062007 0 5 10 15 20 25 30 Breast Cancer Thailand, 1989-2007 Chiang Mai Lampang Khon Kaen Songkhla Year ASR(per100000population
  • 41. Hutcha Sriplung Thai Network of Cancer Registries 41 Male colo-rectal cancer in Thailand 89 90 91 92 93 94 95 96 97 98 99 00 0 5 10 15 20 25 Chiang Mai Lampang Khon Kaen Songkhla Year ASR /100,000 population
  • 42. Hutcha Sriplung Thai Network of Cancer Registries 42 Tobacco consumption and lung cancer in Australia 1945 1947 1949 1951 1953 1955 1957 1959 1961 1963 1965 1967 1969 1971 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 Lung Cancer-Male Lung Cancer-Female Tobacco consumption 3.0 1.5 0.0 2.0 1.0 2.5 Tobacco Kg/capita Death/100,000 population Year AIHW: deloop M & Bhatia K 2001: Australian Health Trends 2001. AIHW Cat. No. PHE 24. Canberra: AIHW; the National Mortality Database. ~20 years
  • 43. The End – Thank you